We are using site-directed mutagenesis of single viral genes to identify and analyze the genetic determinants of human and simian immunodeficiency virus pathogenicity. In a first approach, we have constructed a series of simian immunodeficiency virus SlVmac nef mutants by partial deletion and insertions in the nef gene, as this gene is a candidate gene for the establishment and maintenance of latency. nef insertion mutants replicated faster than wild-type SIVmac, suggesting that the nef gene product acts as a negative factor for replication. Surface phenotyping revealed that cultures permanently infected with nef mutants exhibit an enhanced expression of viral proteins on the outer cell surface. We have analyzed the properties of the mutant viruses in cell culture and intend to use rapidly replicating mutants (putatively unable to undergo latency) as model vaccine viruses in the rhesus monkey.
nef, a regulatory gene of human and simian immunodeficiency viruses (HIV and SIV), is a unique feature of the primate lentiviruses and does not exist in other animal lentiviruses (17) . Conservation of nef in HIV and SIV suggests that the nef protein confers a biological advantage in the evolution and the life cycle of these viruses. The HIV/SIV nef gene encodes a protein of 27 kDa, which is myristylated, phosphorylated, localized in the cytoplasm, and at least partly membrane associated (2) . The nef gene product is not essential for HIV replication (24) . Deletion of nef in an infectious provirus increases its replication in human lymphoblastoid cells (1, 16, 18) , and this observation led to the concept that the nef gene product negatively regulates HIV replication. It was suggested that the target sequences, mediating the suppressive effect of nef, are localized 5' of the RNA initiation site on the long terminal repeat (LTR) between positions -340 and -156 (1, 8) in a region containing negative regulatory elements (17) , although recent publications disagree with these conclusions (10, 12) . Bachelerie et al. (4) observed that constitutive expression of the HIV nef protein in a human astrocyte cell line does not influence basal or induced HIV LTR activity.
Nef shares sequence similarities with members of the proto-oncogene protein family such as p2lras and p60rc (9, 23) . It was furthermore shown that p21 is able to induce transactivation of the HIV-1 LTR (3). These findings led to the prediction that Nef acts in conjunction with other cellular regulatory proteins in a manner similar to that of G proteins (23) . The idea gained support by the demonstration that GTP-binding and GTPase activities are associated with partially purified HIV-1 nefprotein expressed in Escherichia coli (9) . In contrast, other authors could not substantiate that purified HIV-1 nef protein contained GTP-binding or GTPase activity (11 This hypothesis is testable in the SIV/rhesus monkey system, currently the best animal model for human AIDS. We therefore constructed a series of SIVmac nef deletion and insertion mutants for the evaluation of the mutants both in vitro and in vivo. Construction of nef insertion mutants. Stop codons (SMURFT linker; Pharmacia) were introduced into the BgIII (8594) and NcoI (8757) restriction sites (after conversion of protruding 5' ends to blunt ends with E. coli DNA polymerase I Klenow fragment) of pSIVmacBK28-EE, resulting in plasmids pBK28neJBS and pBK28neJNS, respectively.
MATERIALS AND METHODS

Construction
Construction of nef deletion mutants. pSIVmacBK-EE was linearized by restriction with NcoI, subjected to digestion with exonuclease Bal3l, religated, and transformed into E. coli DH5cx competent cells. For all transformants with intact BglII and NdeI (9226) restriction sites, the exact extent of the deletion was determined by dideoxynucleotide sequencing. Three clones carry deletions that do not extend into the U3 region of the LTR: pBK28AneJ3, pBK28zAneJ5, and pBK28Anefl3.
Transfection. SW480 cells (American Type Culture Collection [ATCC]) were grown at 37°C in Dulbecco's modification of Eagle's medium supplemented with 10% (vol/vol) fetal calf serum, 500 jig of penicillin per ml, and 100 ,ug of streptomycin per ml. The different NheI-EcoRI fragments of the mutated nef gene fragments were ligated to the 15-kb pBK28 NheI-EcoRI vector fragment and used to transfect subconfluent cultures of SW480 cells as described previously (5) . One day posttransfection, cultures were cocultivated with Hut78 cells (ATCC) for about 12 h. Infected Hut78 cells were subsequently removed and maintained in RPMI 1640 medium supplemented with 10% (vol/vol) fetal calf serum, 500 jig of penicillin per ml, and 100 pg of streptomycin per ml.
Production and titration of virus stocks. Cell-free culture supernatant from permanently infected Hut78 cell cultures was passed through a 0.22-.Lm-pore-size filter and stored as aliquots in liquid nitrogen. Titration of the virus stocks was performed by endpoint dilution on MT4 cells (ATCC; human T-cell lymphotropic virus type I-transformed T-cell line), and the endpoint was determined by the presence of cytopathic effects in cell culture as described previously (19) .
Reverse transcriptase (RT) assays. The assays were performed according to published procedures (13) .
Immunofluorescence staining and fluorescence-activated cell sorting (FACS) analysis. For cell surface staining viable infected Hut78 were resuspended at 106 cells per ml in AneJ3, -5, and -13 ( Fig. 1; Table 1 ). Every 2 days, cells were split 1:2 and RT activity was determined in the cell-free supernatant. Figure 2 shows the time course of RT activity in the supernatant of the infected cells. The growth kinetics of the different nef mutants were surprising: all SIVmac nef mutants except BK28Anef3 exhibited faster replication kinetics in the initial phase of virus growth than did the wild-type, reaching a plateau at 16 days postinfection (dpi). The growth rates of BK28wt and of BK28/PCRwt (data not shown) were in good agreement.
Compared with the wild type, insertion mutant BK28 nefBS, whose nef protein comprises only the 13 N-terminal amino acids (aa), exhibited an 11-fold-higher RT activity at 10 dpi and mutant BK28neJNS (nef protein of 68 aa) exhibited a 3-fold-higher RT activity (Fig. 3) . In the case of the insertion mutants, the nef protein had been truncated by the introduction of a stop codon in the nef gene although they retained all nef gene-specific nucleotide sequences. proteins on their surface gave an unexpected result: whereas 18% of the cells of the wild-type-infected permanent Hut78 culture stained positively for HIV-2, the percentage of viral neoantigen-expressing cells was higher for all tested nef mutant viruses (BK28nefBS, 26%; BK28AneJ5, 37%; and BK28Anef3, 49%) (Fig. SA) . The observation that even in the case of the deletion mutant Anef3, which has a reduced growth rate, 49% of the cells expressed viral protein on their surface is surprising but not unexplainable. This mutant with its incomplete PPT also integrates into the host's genome, and subsequent virus expression is obviously no longer hampered. CD4 expression is down-regulated to the same extent regardless of whether the cells are infected by the wild type or by the mutant SIVmac strains (Fig. 5B) Our results using nef insertion and deletion mutants clearly indicate such a role, but similar results were not found by others using HIV-1 (11, 13) . However, it should be noted that in our case the faster growth kinetics could be seen only when cultures were infected with a very low MOI, and even under these conditions RT levels were only significantly different between 5 and 12 dpi, after which each virus culture reached an equivalent plateau of virus production. This finding suggests that the mutants replicate and spread through a culture faster than does the wild type but that each culture has a maximum capacity for virus production which all viruses eventually achieve.
The results for the mutants showing increased virus expression as measured by RT activity were supported by the FACS analysis giving the number of infected cells in the acutely infected cultures (Fig. 5) 
